These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5307606)

  • 41. Influence of the substituent radicals in antimonyl naphthalein derivatives on the potentialities of anti-schistosomal activity in mice.
    Ghaleb HA; Shoeb HA; el-Gawhary N; el-Borolossy AW; el-Halawany SA; MADKOUR MK
    J Egypt Med Assoc; 1979; 62(1-2):31-43. PubMed ID: 262474
    [No Abstract]   [Full Text] [Related]  

  • 42. Chemotherapeutic and toxicological properties of antimonyl tartrate-dimethylcysteine chelates.
    Ercoli N
    Proc Soc Exp Biol Med; 1968 Oct; 129(1):284-90. PubMed ID: 5686528
    [No Abstract]   [Full Text] [Related]  

  • 43. Screening of a new synthetic chemical compound with expected antibilharzial properties.
    Galal EE; Nasr A; Shinawy AM; Baraka Y; Mahmoud MA; Azzam B; el Far N
    J Egypt Med Assoc; 1965; 48():Suppl:127-51. PubMed ID: 5873669
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro effects of some antimonial and non-antimonial schistosomicidal drugs on liver beta-glucuronidase enzyme activity.
    El-Sewedy SM; El-Melegy S; Akhnoukh S; Sallam N; Abdel-Rafaa A
    Biochem Pharmacol; 1980 Nov; 29(21):2925-7. PubMed ID: 7458947
    [No Abstract]   [Full Text] [Related]  

  • 45. Trial of Astiban in treating university students in the Sudan.
    Hamad B
    J Trop Med Hyg; 1969 Sep; 72(9):229-30. PubMed ID: 4899483
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparative study of electrocardiographic changes determined by treatment with tri- and pentavalent antimony].
    de Lacerda Júnior FS; Ferminiani H; da Mota CC; Baranski C
    Rev Inst Med Trop Sao Paulo; 1965; 7(4):210-7. PubMed ID: 5854944
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of schistosomiasis. Factors affecting chemotherapy and reflections on ideal drug treatment.
    McMahon JE
    Trop Geogr Med; 1978 Jun; 30(2):161-74. PubMed ID: 103260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapeutic studies on experimental Schistosoma mansoni infection of Mastomys natalensis.
    Lämmler G; Petrányi G
    Bull World Health Organ; 1971; 44(6):739-50. PubMed ID: 5317444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A new promising drug against schistosomiasis].
    Dissous C; Ahier A; Long T
    Med Sci (Paris); 2009 Jan; 25(1):24-6. PubMed ID: 19154688
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug resistance and drug tolerance in parasites.
    Coles GC
    Trends Parasitol; 2006 Aug; 22(8):348; author reply 349. PubMed ID: 16765645
    [No Abstract]   [Full Text] [Related]  

  • 51. Schistosomiasis Japonica. Treatment by extracorporeal hemofiltration.
    Kean BH; Goldsmith EI
    Am J Med; 1969 Oct; 47(4):546-52. PubMed ID: 5822977
    [No Abstract]   [Full Text] [Related]  

  • 52. Effectiveness of a single dose of hycanthone orally in experimental schistosomiasis in hamsters.
    Khayyal MT; Girgis NI
    Bull World Health Organ; 1969; 40(6):963-5. PubMed ID: 5307607
    [No Abstract]   [Full Text] [Related]  

  • 53. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R; Valderrama L; Valderrama M; Varona MX; Ouellette M; Saravia NG
    J Infect Dis; 2006 May; 193(10):1375-83. PubMed ID: 16619185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Re-positioning protein-kinase inhibitors against schistosomiasis.
    Gelmedin V; Dissous C; Grevelding CG
    Future Med Chem; 2015; 7(6):737-52. PubMed ID: 25996067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of schistosomicidals on lung ventilation in bilharzial cases.
    Mousa AH; El-Garem A; El-Hawey AM; Abdel-Latif EA
    J Egypt Med Assoc; 1968; 51(9):765-81. PubMed ID: 5711101
    [No Abstract]   [Full Text] [Related]  

  • 56. Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline.
    Ramamoorthi R; Graef KM; Dent J
    Future Med Chem; 2015; 7(6):727-35. PubMed ID: 25996066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The action of metrifonate on 3 species of schistosomes.
    James C; Webbe G; Preston JM
    Trans R Soc Trop Med Hyg; 1972; 66(4):531. PubMed ID: 5071054
    [No Abstract]   [Full Text] [Related]  

  • 58. The fate and behaviour of antimonial drugs labelled with 124 Sb in bilharzial subjects.
    Abdel-Wahab MF; el-Raziky EH; Abdulla WA; el-Garhi MZ
    Egypt J Bilharz; 1974; 1(1):107-15. PubMed ID: 4420438
    [No Abstract]   [Full Text] [Related]  

  • 59. [Advances in research on antischistosomal drugs].
    Qiu SJ; Xia CM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of egg production of Schistosoma mansoni in mice treated with nicarbazin.
    Campbell WC; Cuckler AC
    J Parasitol; 1967 Oct; 53(5):977-80. PubMed ID: 6070373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.